Atrial fibrillation in chronic non-cardiac disease: Where do we stand?

Mitja Lainscak; Nikolaos Dagres; Gerasimos S. Filippatos; Stefan D. Anker; Dimitrios Th Kremastinos

doi:10.1016/j.ijcard.2007.12.078

Atrial fibrillation in chronic non-cardiac disease: Where do we stand?

Mitja Lainscak, Nikolaos Dagres, Gerasimos S. Filippatos, Stefan D. Anker, Dimitrios Th Kremastinos

Istituto San Raffaele Pisana

Research output: Contribution to journal › Article

Abstract

Atrial fibrillation is the most common arrhythmia, and is associated with increased risk of stroke and death. Most of present knowledge is derived from studies in patients with cardiac disease whilst limited information is available for patients with several chronic non-cardiac conditions like cancer, chronic obstructive pulmonary disease and chronic kidney disease. Although millions of patients are affected and are at risk of adverse prognosis due to co-existent atrial fibrillation, we are left with very limited guidance for management of atrial fibrillation itself and prevention of complications in those patients. In this paper, we review data on incidence, prognostic importance and treatment modalities of atrial fibrillation in patients with cancer, chronic obstructive pulmonary disease, and chronic kidney disease.

Original language	English
Pages (from-to)	311-315
Number of pages	5
Journal	International Journal of Cardiology
Volume	128
Issue number	3
DOIs	https://doi.org/10.1016/j.ijcard.2007.12.078
Publication status	Published - Aug 29 2008

Keywords

Atrial fibrillation
Cancer
Chronic kidney disease
Chronic obstructive pulmonary disease

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ijcard.2007.12.078

Fingerprint Dive into the research topics of 'Atrial fibrillation in chronic non-cardiac disease: Where do we stand?'. Together they form a unique fingerprint.

Cite this

Lainscak, M., Dagres, N., Filippatos, G. S., Anker, S. D., & Kremastinos, D. T. (2008). Atrial fibrillation in chronic non-cardiac disease: Where do we stand? International Journal of Cardiology, 128(3), 311-315. https://doi.org/10.1016/j.ijcard.2007.12.078

@article{84b9b3b7858d46eba460adbb049d1d72,

title = "Atrial fibrillation in chronic non-cardiac disease: Where do we stand?",

abstract = "Atrial fibrillation is the most common arrhythmia, and is associated with increased risk of stroke and death. Most of present knowledge is derived from studies in patients with cardiac disease whilst limited information is available for patients with several chronic non-cardiac conditions like cancer, chronic obstructive pulmonary disease and chronic kidney disease. Although millions of patients are affected and are at risk of adverse prognosis due to co-existent atrial fibrillation, we are left with very limited guidance for management of atrial fibrillation itself and prevention of complications in those patients. In this paper, we review data on incidence, prognostic importance and treatment modalities of atrial fibrillation in patients with cancer, chronic obstructive pulmonary disease, and chronic kidney disease.",

keywords = "Atrial fibrillation, Cancer, Chronic kidney disease, Chronic obstructive pulmonary disease",

author = "Mitja Lainscak and Nikolaos Dagres and Filippatos, {Gerasimos S.} and Anker, {Stefan D.} and Kremastinos, {Dimitrios Th}",

year = "2008",

month = aug,

day = "29",

doi = "10.1016/j.ijcard.2007.12.078",

language = "English",

volume = "128",

pages = "311--315",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - Atrial fibrillation in chronic non-cardiac disease

T2 - Where do we stand?

AU - Lainscak, Mitja

AU - Dagres, Nikolaos

AU - Filippatos, Gerasimos S.

AU - Anker, Stefan D.

AU - Kremastinos, Dimitrios Th

PY - 2008/8/29

Y1 - 2008/8/29

N2 - Atrial fibrillation is the most common arrhythmia, and is associated with increased risk of stroke and death. Most of present knowledge is derived from studies in patients with cardiac disease whilst limited information is available for patients with several chronic non-cardiac conditions like cancer, chronic obstructive pulmonary disease and chronic kidney disease. Although millions of patients are affected and are at risk of adverse prognosis due to co-existent atrial fibrillation, we are left with very limited guidance for management of atrial fibrillation itself and prevention of complications in those patients. In this paper, we review data on incidence, prognostic importance and treatment modalities of atrial fibrillation in patients with cancer, chronic obstructive pulmonary disease, and chronic kidney disease.

AB - Atrial fibrillation is the most common arrhythmia, and is associated with increased risk of stroke and death. Most of present knowledge is derived from studies in patients with cardiac disease whilst limited information is available for patients with several chronic non-cardiac conditions like cancer, chronic obstructive pulmonary disease and chronic kidney disease. Although millions of patients are affected and are at risk of adverse prognosis due to co-existent atrial fibrillation, we are left with very limited guidance for management of atrial fibrillation itself and prevention of complications in those patients. In this paper, we review data on incidence, prognostic importance and treatment modalities of atrial fibrillation in patients with cancer, chronic obstructive pulmonary disease, and chronic kidney disease.

KW - Atrial fibrillation

KW - Cancer

KW - Chronic kidney disease

KW - Chronic obstructive pulmonary disease

UR - http://www.scopus.com/inward/record.url?scp=48349084381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48349084381&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2007.12.078

DO - 10.1016/j.ijcard.2007.12.078

M3 - Article

C2 - 18374999

AN - SCOPUS:48349084381

VL - 128

SP - 311

EP - 315

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 3

ER -